Navigation Links
NeuroCog Trials Appoints Industry Executive Michael Hufford, Ph.D. to Chief Operating Officer
Date:11/4/2011

DURHAM, N.C., Nov. 4, 2011 /PRNewswire/ -- NeuroCog Trials, Inc. today announced the appointment of Michael R. Hufford, Ph.D. to the position of Chief Operating Officer.  In this newly created position, Dr. Hufford will assume responsibility for the continued growth and expansion of NeuroCog Trials' business, research and development, and operations.

"The investment in research and development for pro-cognitive therapies across a wide variety of therapeutic areas has never been stronger.  As NeuroCog Trials continues to grow to meet these needs, we decided that it was time to bring someone on board with a proven track record of success on both the vendor and sponsor side of clinical research," said Richard Keefe, Ph.D., Founder and Chief Executive Officer at NeuroCog Trials. "We are delighted to have Dr. Hufford bring the wealth of his experience in industry, academia and entrepreneurship to NeuroCog Trials.  His role at NeuroCog represents a real advance for us in our ability to provide key services for increasingly larger trials across a broad range of CNS and other therapeutic areas."

Dr. Hufford brings to the company more than 14 years of experience in clinical research and drug development.  Prior to joining NeuroCog Trials, he was Vice President of Clinical Development at Cypress Bioscience, where he was responsible for drug and medical device development for multiple CNS programs.  Before joining Cypress, he worked at Amylin Pharmaceuticals, leading drug development teams focused on orphan drug development for rare metabolic diseases, combination peptide and protein therapies for obesity, and helped to spinout and was on the board of Psylin Neurosciences.  Between 2000 and 2005, Dr. Hufford was Vice President of Scientific Affairs at invivodata, inc., an electronic patient-reported outcomes company.  Prior to that, he was an Assistant Professor of Clinical Psychology at the University of Montana.  
'/>"/>

SOURCE NeuroCog Trials, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Data From REMEDEE Trial Featuring OrbusNeichs Combo™ Dual Therapy Stent to be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011
2. CTRI Confirms Leading Indian CRO Supports Majority of Hemophilia Trials in India
3. QIAGEN to Develop New Companion Diagnostic for Compound in Clinical Trials for Blood Cancers
4. Kibow Biotech, Inc. Secures $2.4 Million Towards Its Human Clinical Trials by Continued Veterinary Licensing Agreement
5. Middle East to be the Future in Clincial Trials
6. Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule Revamilast
7. Start of in-Patient Clinical Trials With NT-KO-003, the First Neuroprotective Drug for Multiple Sclerosis Without Immunosuppressive Effects
8. Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in the US and Europe
9. Drug Dropout in Clinical Trials Is at Unsustainable Levels, According to Thomson Reuters, CMR International
10. ERA-EDTA Congress 2011: Late Breaking Clinical Trials I
11. ACT Announces First Patients Enrolled in Two Clinical Trials Using Embryonic Stem Cells to Treat Stargardts Disease and Dry Age-Related Macular Degeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014 Unraveling life’s mysteries can intrigue, ... Archer Family purchased a DNA test to ... up with a lifetime of memories, sharing, and closeness. ... members’ DNA genuinely brought the family closer together. ... into genetic history and prior to taking the ...
(Date:7/10/2014)... 2014 EvoDerma ’s NOOME Anti-Aging Motion ... device now comes with a second treatment cup to help ... The new cup is thinner on the edges for a ... rough, thin and uneven surfaces on the face, neck and ... stimulating treatment on areas such as the cheeks and neck, ...
(Date:7/10/2014)... , July 10, 2014 ... Dmitry Medvedev , presented Russia,s ... BIOCAD . The Company is developing a unique ... MabNext project BIOCAD develops a number of innovative drugs ... autoimmune diseases. The ceremony took place at the International ...
(Date:7/10/2014)... -- Research and Markets ( http://www.researchandmarkets.com/research/s3bqj2/photonic ) has ... Integrated Circuit (Monolithic Integration, Hybrid Integration, Module Integration) ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... traces its roots in the latter half of ... went unexplored and unfulfilled for several decades owing ...
Breaking Biology Technology:Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 2Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 3Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 4Ancestry DNA Test Reveals a Controversial and Undiscovered Family History 5Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2International Photonic Integrated Circuit (Monolithic Integration, Hybrid Integration, Module Integration) Market - Forecasts to 2019 2
... Philadelphia Firms to Help Stimulate ... is setting the stage for future opportunity and innovation ... life science industry, Governor Edward G. Rendell said today ... that will help stimulate growth in the state,s rapidly ...
... Pharmaceuticals Inc. (Nasdaq: VNDA ) announced today ... atypical antipsychotic, Fanapt(TM) (iloperidone), at the 162nd American Psychiatric ... Fanapt(TM) is indicated for the acute treatment of schizophrenia ... on tasimelteon at APA. Tasimelteon is an investigational ...
... Spherix Incorporated (Nasdaq: SPEX ), an innovator ... technical and regulatory consulting services to food, supplement, biotechnology ... at the 2009 BIO International Conference in Atlanta, Georgia ... Obesity Control Drug" booth will showcase their ongoing global ...
Cached Biology Technology:Venture Capitalists to Invest in Promising PA Life Science Companies, Governor Rendell Says 2Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting 2Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting 3Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting 4Spherix to Exhibit at the BIO 2009 International Convention 2
(Date:7/11/2014)... of kidney injury related to the use of hydroxyethyl ... HES molecules, according to a report in Anesthesia ... Research Society (IARS). , The "total mass of HES ... human renal proximal tubule cells (PTCs), concludes the laboratory ... Hospital Wrzburg, Austria. Other factorssuch as differences in ...
(Date:7/11/2014)... to the hippocampus, the marginal division of the ... What is the impact degree of substance P ... memory function? Yan Yu and his team, College ... using immunofluorescence staining, that substance P receptor, neurokinin ... striatal marginal division of normal rats. Unilateral or ...
(Date:7/11/2014)... Evidence exists that cannabinoid receptor type 1 ... Ca2+ influx, and reduce neurotransmitter release. However, ... 1 can increase extracellular Ca2+ influx and ... his team, Tongji Hospital Affiliated to Tongji ... Technology, China used whole cell voltage-clamp and ...
Breaking Biology News(10 mins):In lab studies, hydroxyethyl starch has direct harmful effects on kidney cells 2
... team of Australian researchers, led by University of Melbourne has ... risk of developing Autism Spectrum Disorder, ASD. Lead researcher ... at the University of Melbourne said the test could be ... "This test could assist in the early detection of the ...
... PARSONS, W. Va., September 12, 2012 Using old ... has created a glimpse of the composition of the ... and logging changed the landscape., "European Settlement-Era Vegetation of ... Forest Service scientist and her West Virginia University colleague ...
... called exons, which code for the synthesis of proteins, ... predict the different regions in a new and unannotated ... today. Now researchers at the Indian Institute of Technology ... identify DNA introns and exons an order of magnitude ...
Cached Biology News:Genetic test predicts risk for Autism 2Old deeds, witness trees offer glimpse of pre-settlement forest in West Virginia 2Old deeds, witness trees offer glimpse of pre-settlement forest in West Virginia 3
Monoclonal Mouse Anti-Human Cytokeratin 16 (48 kD)...
Sheep polyclonal to Melatonin ( Abpromise for all tested applications). Antigen: Melatonin Tg conjugate....
Rabbit polyclonal to NCoR2, prediluted ( Abpromise for all tested applications). entrezGeneID: 9612 SwissProtID: Q9Y618...
Rabbit polyclonal to TRPM8 (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 79054 SwissProtID: Q3YFM7...
Biology Products: